Pyrazolo[1,5-a]pyrimidin-5-ol

Catalog No.: 
ACDNVC543
CAS No.: 
29274-22-4
Molecular Formula: 
C6H5N3O
Molecular Weight: 
135.13
Pyrazolo[1,5-a]pyrimidin-5-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$110.00In stockIn stock
100g98%$355.00In stockIn stock
500g98%$1566.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyrazolo[1,5-a]pyrimidin-5-ol
IUPAC Namepyrazolo[1,5-a]pyrimidin-5-ol
MDL No.MFCD04035685
Molecular FormulaC6H5N3O
Molecular Weight135.13
SMILESOC1=NC2=CC=NN2C=C1
InChI KeyLSLIYLLMLAQRIS-UHFFFAOYSA-N
SynonymBG-0010 | CS-0160345 | FT-0681735 | SY019321 | Z1966571755 | J-517618 | pyrazolo[1,5-a]pyrimidin-5(4H)-one | 1H-PYRAZOLO[1,5-A]PYRIMIDIN-5-ONE | 4H-pyrazolo[1,5-a]pyrimidin-5-one | GM 14 | P11730 | AKOS005073888 | DTXSID70582949 | PB28532 | Pyrazolo[1 pou
CAS No.29274-22-4
PubChem CID135513288

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACDNVC543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDNVC543 route product structure diagram
    ACDNVC54329274-22-4In Stock
Inquiry

2. ACDNVC543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACDNVC543 route product structure diagram
    ACDNVC54329274-22-4In Stock
Inquiry

3. ACDNVC543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDNVC543 route product structure diagram
    ACDNVC54329274-22-4In Stock
Inquiry

Comments (0)